This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Treatment of Anemia in the 2nd Year of Life. Comparison of the Efficacy of Two Different Iron Preparations.

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified April 2008 by Soroka University Medical Center.
Recruitment status was:  Recruiting
Information provided by:
Soroka University Medical Center Identifier:
First received: November 3, 2005
Last updated: April 29, 2008
Last verified: April 2008

Healthy toddlers (age 9-18 month) following a routine blood count will be placed in three groups:

  1. Iron deficiency with no anemia
  2. anemia
  3. no anemia and no iron deficiency Following a nutritional questionnaire, parents of all toddlers will receive instruction regarding appropriate nutrition in the 2nd year of life. Groups 1 and 2 will randomly receive one of two preparations currently in use for treatment of iron deficiency in Israel (Aktiron 35 - Ferrous gluconate and Ferripel-3 - iron polysaccharide complex). Followup blood count will be taken 3 month after recruitment. The study aims to compare the effectiveness of the Iron preparations regarding compliance and efficacy.

The hypothesis is that a significant difference will be detected between the two preparations.

Condition Intervention Phase
Iron Deficiency Anemia Drug: Ferrous gluconate and iron polysaccharide complex Phase 4

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment

Resource links provided by NLM:

Further study details as provided by Soroka University Medical Center:

Primary Outcome Measures:
  • Hemoglobin [ Time Frame: 3 months ]

Estimated Enrollment: 200
Study Start Date: February 2007
Estimated Primary Completion Date: April 2009 (Final data collection date for primary outcome measure)
Intervention Details:
    Drug: Ferrous gluconate and iron polysaccharide complex
    Children with anemia will receive 5mg per kg per day of one of study medications. Treatment period for 3 months

Ages Eligible for Study:   9 Months to 18 Months   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Healthy toddlers age 9-18 months

Exclusion Criteria:

  • Toddlers with: chronic diseases, prematurity, inherited hematological disease.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00248716

Contact: Jacob Urkin, MD, MPH 972-8-6477480

Primary Pediatric Care Unit, Ben-Gurion University of the Negev Recruiting
Beer-Sheva, Israel, 84105
Contact: Jacob Urkin, MD, MPH    972-8-6477480   
Sponsors and Collaborators
Soroka University Medical Center
Principal Investigator: Jacob Urkin, MD, MPH Ben-Gurion University of the Negev
  More Information

Responsible Party: Dr Jacob Urkin, Ben-Gurion University of the Negev Identifier: NCT00248716     History of Changes
Other Study ID Numbers: sor458607ctil
Study First Received: November 3, 2005
Last Updated: April 29, 2008

Additional relevant MeSH terms:
Anemia, Iron-Deficiency
Hematologic Diseases
Anemia, Hypochromic
Iron Metabolism Disorders
Metabolic Diseases
Ferrous gluconate
Trace Elements
Growth Substances
Physiological Effects of Drugs processed this record on September 21, 2017